{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T03:58:38Z","timestamp":1759118318387,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00204-025-04162-5","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T02:21:33Z","timestamp":1756174893000},"page":"4677-4696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An evaluation of the human relevance of the thyroid follicular cell tumors observed in rats treated with the synthetic fungicide, pyridachlometyl, based on mode of action"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3775-2912","authenticated-orcid":false,"given":"Kensuke","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Shimotsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoki","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"1","key":"4162_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10408444.2013.835785","volume":"44","author":"ME Andersen","year":"2014","unstructured":"Andersen ME, Preston RJ, Maier A, Willis AM, Patterson J (2014) Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: results of a workshop. Crit Rev Toxicol 44(1):50\u201363","journal-title":"Crit Rev Toxicol"},{"issue":"5","key":"4162_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0278-6915(91)90206-M","volume":"29","author":"CK Atterwill","year":"1991","unstructured":"Atterwill CK, Hillier G (1991) Comparative studies on the effect of noxythiolin and other thioureas on the thyroid using in vitro and in vivo models of thyroid function. Food Chem Toxicol 29(5):355\u2013359","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"4162_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0160-5402(87)90070-2","volume":"18","author":"CK Atterwill","year":"1987","unstructured":"Atterwill CK, Collins P, Brown CG, Harland RF (1987) The perchlorate discharge test for examining thyroid function in rats. J Pharmacol Methods 18(3):199\u2013203","journal-title":"J Pharmacol Methods"},{"key":"4162_CR4","unstructured":"Atterwill CK, Flack JD (eds) (1992) Endocrine toxicology. Thyroid gland II\u2014mechanisms of species-dependent thyroid toxicity, hyperplasia and neoplasia induced by xenobiotics, the Press Syndicate of the University of Cambridge"},{"key":"4162_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yrtph.2018.07.025","volume":"98","author":"R Bartsch","year":"2018","unstructured":"Bartsch R, Brinkmann B, Jahnke G, Laube B, Lohmann R, Michaelsen S, Neumann I, Greim H (2018) Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances. Regul Toxicol Pharmacol 98:199\u2013208","journal-title":"Regul Toxicol Pharmacol"},{"issue":"10","key":"4162_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/10408440600977677","volume":"36","author":"AR Boobis","year":"2006","unstructured":"Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W (2006) IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36(10):781\u2013792","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"4162_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/019262339702500109","volume":"25","author":"CC Capen","year":"1997","unstructured":"Capen CC (1997) Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol 25(1):39\u201348","journal-title":"Toxicol Pathol"},{"key":"4162_CR8","unstructured":"Capen CC, Dybing E, Rice JM, Wilbourn JD (1999) Species differences in thyroid, kidney and urinary bladder carcinogenesis (IARC scientific publications no. 147). International Agency for Research on Cancer, Lyon"},{"issue":"3","key":"4162_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.yrtph.2007.04.007","volume":"48","author":"G Coelho-Palermo Cunha","year":"2007","unstructured":"Coelho-Palermo Cunha G, van Ravenzwaay B (2007) Standardization of the perchlorate discharge assay for thyroid toxicity testing in rats. Regul Toxicol Pharmacol 48(3):270\u2013278","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"4162_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1293\/tox.2016-0036","volume":"29","author":"SM Cohen","year":"2016","unstructured":"Cohen SM, Arnold LL (2016) Critical role of toxicologic pathology in a short-term screen for carcinogenicity. J Toxicol Pathol 29(4):215\u2013227","journal-title":"J Toxicol Pathol"},{"issue":"2","key":"4162_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/toxsci\/kfh073","volume":"78","author":"SM Cohen","year":"2004","unstructured":"Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, Dellarco V, Fenner-Crisp P, Patton D (2004) Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78(2):181\u2013186","journal-title":"Toxicol Sci"},{"issue":"1","key":"4162_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/toxsci\/kfp006","volume":"108","author":"Y Deguchi","year":"2009","unstructured":"Deguchi Y, Yamada T, Hirose Y, Nagahori H, Kushida M, Sumida K, Sukata T, Tomigahara Y, Nishioka K, Uwagawa S, Kawamura S, Okuno Y (2009) Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation. Toxicol Sci 108(1):69\u201380","journal-title":"Toxicol Sci"},{"issue":"10","key":"4162_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/10408440600975242","volume":"36","author":"VL Dellarco","year":"2006","unstructured":"Dellarco VL, McGregor D, Berry SC, Cohen SM, Boobis AR (2006) Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action. Crit Rev Toxicol 36(10):793\u2013801","journal-title":"Crit Rev Toxicol"},{"issue":"1\u20133","key":"4162_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0163-7258(79)90099-8","volume":"5","author":"KD Dohler","year":"1979","unstructured":"Dohler KD, Wong CC, von zur Muhlen A (1979) The rat as model for the study of drug effects on thyroid function: consideration of methodological problems. Pharmacol Ther B 5(1\u20133):305\u2013318","journal-title":"Pharmacol Ther B"},{"key":"4162_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tiv.2019.01.021","volume":"57","author":"H Dong","year":"2019","unstructured":"Dong H, Atlas E, Wade MG (2019) Development of a non-radioactive screening assay to detect chemicals disrupting the human sodium iodide symporter activity. Toxicol in Vitro 57:39\u201347","journal-title":"Toxicol in Vitro"},{"key":"4162_CR16","unstructured":"ECHA (2024) Guidance on the application of the CLP criteria: guidance to regulation (EC) no. 1272\/2008 on classification, labelling, and packaging (CLP) of substances and mixtures version 6.0"},{"issue":"3","key":"4162_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.taap.2006.01.009","volume":"214","author":"JM Finch","year":"2006","unstructured":"Finch JM, Osimitz TG, Gabriel KL, Martin T, Henderson WJ, Capen CC, Butler WH, Lake BG (2006) A mode of action for induction of thyroid gland tumors by pyrethrins in the rat. Toxicol Appl Pharmacol 214(3):253\u2013262","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"4162_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00204-020-02961-6","volume":"95","author":"JR Foster","year":"2021","unstructured":"Foster JR, Tinwell H, Melching-Kollmuss S (2021) A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer. Arch Toxicol 95(3):807\u2013836","journal-title":"Arch Toxicol"},{"key":"4162_CR19","unstructured":"FSCJ (2022) Risk assessment report. Pyridachlometyl (Japanese). http:\/\/www.fsc.go.jp\/fsciis\/attachedFile\/download?retrievalId=kya20220323038&fileId=210"},{"issue":"2","key":"4162_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/00498254.2018.1437300","volume":"49","author":"C Haines","year":"2019","unstructured":"Haines C, Chatham LR, Vardy A, Elcombe CR, Foster JR, Lake BG (2019) Comparison of the hepatic and thyroid gland effects of sodium phenobarbital and pregnenolone-16alpha-carbonitrile in wild-type and constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) knockout rats. Xenobiotica 49(2):227\u2013238","journal-title":"Xenobiotica"},{"issue":"8","key":"4162_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1289\/ehp.98106447","volume":"106","author":"RN Hill","year":"1998","unstructured":"Hill RN, Crisp TM, Hurley PM, Rosenthal SL, Singh DV (1998) Risk assessment of thyroid follicular cell tumors. Environ Health Perspect 106(8):447\u2013457","journal-title":"Environ Health Perspect"},{"issue":"1","key":"4162_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/toxsci\/50.1.45","volume":"50","author":"A Hood","year":"1999","unstructured":"Hood A, Liu J, Klaassen CD (1999a) Effects of phenobarbital, pregnenolone-16alpha-carbonitrile, and propylthiouracil on thyroid follicular cell proliferation. Toxicol Sci 50(1):45\u201353","journal-title":"Toxicol Sci"},{"issue":"2","key":"4162_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/toxsci\/49.2.263","volume":"49","author":"A Hood","year":"1999","unstructured":"Hood A, Liu YP, Gattone VH 2nd, Klaassen CD (1999b) Sensitivity of thyroid gland growth to thyroid stimulating hormone (TSH) in rats treated with antithyroid drugs. Toxicol Sci 49(2):263\u2013271","journal-title":"Toxicol Sci"},{"issue":"8","key":"4162_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1177\/0192623320972009","volume":"48","author":"M Huisinga","year":"2020","unstructured":"Huisinga M, Bertrand L, Chamanza R, Damiani I, Engelhardt J, Francke S, Freyberger A, Harada T, Harleman J, Kaufmann W, Keane K, Kohrle J, Lenz B, Marty MS, Melching-Kollmuss S, Palazzi X, Pohlmeyer-Esch G, Popp A, Rosol TJ, Strauss V, Van den Brink-Knol H, Wood CE, Yoshida M (2020) Adversity considerations for thyroid follicular cell hypertrophy and hyperplasia in nonclinical toxicity studies: results from the 6th ESTP international expert workshop. Toxicol Pathol 48(8):920\u2013938","journal-title":"Toxicol Pathol"},{"issue":"8","key":"4162_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1289\/ehp.98106437","volume":"106","author":"PM Hurley","year":"1998","unstructured":"Hurley PM (1998) Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ Health Perspect 106(8):437\u2013445","journal-title":"Environ Health Perspect"},{"issue":"3","key":"4162_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1293\/tox.2016-0005","volume":"29","author":"K Isobe","year":"2016","unstructured":"Isobe K, Mukaratirwa S, Petterino C, Bradley A (2016) Historical control background incidence of spontaneous thyroid and parathyroid glands lesions of rats and CD-1 mice used in 104-week carcinogenicity studies. J Toxicol Pathol 29(3):201\u2013206","journal-title":"J Toxicol Pathol"},{"key":"4162_CR27","doi-asserted-by":"crossref","unstructured":"Kawamoto K, Shimotsuma Y, Maeda K, Matsunaga K, Asano H, Cohen SM, Yamada T (2025) An evaluation of the human relevance of the hepatocellular tumors observed in mice treated with synthetic fungicide, pyridachlometyl, based on mode of action. Arch Toxicol","DOI":"10.1007\/s00204-025-04099-9"},{"issue":"2","key":"4162_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/endo-98-2-295","volume":"98","author":"JD Kieffer","year":"1976","unstructured":"Kieffer JD, Mover H, Federico P, Maloof F (1976) Pituitary-thyroid axis in neonatal and adult rats: comparison of the sexes. Endocrinology 98(2):295\u2013304","journal-title":"Endocrinology"},{"issue":"1","key":"4162_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/019262301301418838","volume":"29","author":"CD Klaassen","year":"2001","unstructured":"Klaassen CD, Hood AM (2001) Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism. Toxicol Pathol 29(1):34\u201340","journal-title":"Toxicol Pathol"},{"issue":"3","key":"4162_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0016-6480(85)90108-X","volume":"58","author":"M Larsson","year":"1985","unstructured":"Larsson M, Pettersson T, Carlstrom A (1985) Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. Gen Comp Endocrinol 58(3):360\u2013375","journal-title":"Gen Comp Endocrinol"},{"issue":"6","key":"4162_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/713608373","volume":"33","author":"ME Meek","year":"2003","unstructured":"Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE (2003) A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33(6):591\u2013653","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"4162_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jat.2949","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C (2014a) New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis. J Appl Toxicol 34(1):1\u201318","journal-title":"J Appl Toxicol"},{"issue":"6","key":"4162_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jat.2984","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R (2014b) Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol 34(6):595\u2013606","journal-title":"J Appl Toxicol"},{"key":"4162_CR34","unstructured":"OECD (2018) Revised guidance document 150 on standardised test guidelines for evaluating chemicals for endocrine disruption, OECD series on testing and assessment, no. 150. OECD Publishing, Paris"},{"issue":"2","key":"4162_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/toxsci\/kfx102","volume":"158","author":"Y Okuda","year":"2017","unstructured":"Okuda Y, Kushida M, Sumida K, Nagahori H, Nakamura Y, Higuchi H, Kawamura S, Lake BG, Cohen SM, Yamada T (2017) Mode of action analysis for rat hepatocellular tumors produced by the synthetic pyrethroid momfluorothrin: evidence for activation of the constitutive androstane receptor (CAR) and mitogenicity in rat hepatocytes. Toxicol Sci 158(2):412\u2013430","journal-title":"Toxicol Sci"},{"issue":"3","key":"4162_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.yrtph.2015.02.012","volume":"71","author":"S Papineni","year":"2015","unstructured":"Papineni S, Marty MS, Rasoulpour RJ, LeBaron MJ, Pottenger LH, Eisenbrandt DL (2015) Mode of action and human relevance of pronamide-induced rat thyroid tumors. Regul Toxicol Pharmacol 71(3):541\u2013551","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"4162_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/tx400310w","volume":"27","author":"KB Paul","year":"2014","unstructured":"Paul KB, Hedge JM, Rotroff DM, Hornung MW, Crofton KM, Simmons SO (2014) Development of a thyroperoxidase inhibition assay for high-throughput screening. Chem Res Toxicol 27(3):387\u2013399","journal-title":"Chem Res Toxicol"},{"issue":"9","key":"4162_CR38","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/10408440701524949","volume":"37","author":"LR Rhomberg","year":"2007","unstructured":"Rhomberg LR, Baetcke K, Blancato J, Bus J, Cohen S, Conolly R, Dixit R, Doe J, Ekelman K, Fenner-Crisp P, Harvey P, Hattis D, Jacobs A, Jacobson-Kram D, Lewandowski T, Liteplo R, Pelkonen O, Rice J, Somers D, Turturro A, West W, Olin S (2007) Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. Crit Rev Toxicol 37(9):729\u2013837","journal-title":"Crit Rev Toxicol"},{"issue":"8","key":"4162_CR39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1177\/0192623313482055","volume":"41","author":"Y Sakamoto","year":"2013","unstructured":"Sakamoto Y, Inoue K, Takahashi M, Taketa Y, Kodama Y, Nemoto K, Degawa M, Gamou T, Ozawa S, Nishikawa A, Yoshida M (2013) Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether. Toxicol Pathol 41(8):1078\u20131092","journal-title":"Toxicol Pathol"},{"issue":"8\u20139","key":"4162_CR40","first-page":"664","volume":"35","author":"J Seed","year":"2005","unstructured":"Seed J, Carney EW, Corley RA, Crofton KM, DeSesso JM, Foster PM, Kavlock R, Kimmel G, Klaunig J, Meek ME, Preston RJ, Slikker W Jr, Tabacova S, Williams GM, Wiltse J, Zoeller RT, Fenner-Crisp P, Patton DE (2005) Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol 35(8\u20139):664\u2013672","journal-title":"Crit Rev Toxicol"},{"issue":"2","key":"4162_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/rtph.2001.1493","volume":"34","author":"C Sonich-Mullin","year":"2001","unstructured":"Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, Mangelsdorf I, Meek E, Rice JM, Younes M (2001) IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34(2):146\u2013152","journal-title":"Regul Toxicol Pharmacol"},{"key":"4162_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104736","volume":"117","author":"C Strupp","year":"2020","unstructured":"Strupp C, Quesnot N, Weber-Parmentier C, Richert L, Bomann WH, Singh P (2020) Weight of evidence and human relevance evaluation of the Benfluralin mode of action in rats (part II): thyroid carcinogenesis. Regul Toxicol Pharmacol 117:104736","journal-title":"Regul Toxicol Pharmacol"},{"key":"4162_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713246","author":"C Strupp","year":"2023","unstructured":"Strupp C, Corvaro M, Cohen SM, Corton JC, Ogawa K, Richert L, Jacobs MN (2023) Increased cell proliferation as a key event in chemical carcinogenesis: application in an integrated approach for the testing and assessment of non-genotoxic carcinogenesis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713246","journal-title":"Int J Mol Sci"},{"key":"4162_CR44","unstructured":"US.EPA (1998) Assessment of thyroid follicular cell tumors (EPA\/630\/R-97\/002)"},{"issue":"1","key":"4162_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-291X(90)91767-M","volume":"167","author":"R Vranckx","year":"1990","unstructured":"Vranckx R, Rouaze M, Savu L, Nunez EA, Beaumont C, Flink IL (1990) The hepatic biosynthesis of rat thyroxine binding globulin (TBG): demonstration, ontogenesis, and up-regulation in experimental hypothyroidism. Biochem Biophys Res Commun 167(1):317\u2013322","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4162_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/toxsci\/67.2.207","volume":"67","author":"MG Wade","year":"2002","unstructured":"Wade MG, Parent S, Finnson KW, Foster W, Younglai E, McMahon A, Cyr DG, Hughes C (2002) Thyroid toxicity due to subchronic exposure to a complex mixture of 16 organochlorines, lead, and cadmium. Toxicol Sci 67(2):207\u2013218","journal-title":"Toxicol Sci"},{"issue":"6","key":"4162_CR47","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/0192623315576005","volume":"43","author":"CE Wood","year":"2015","unstructured":"Wood CE, Hukkanen RR, Sura R, Jacobson-Kram D, Nolte T, Odin M, Cohen SM (2015) Scientific and regulatory policy committee (SRPC) review*: interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol 43(6):760\u2013775","journal-title":"Toxicol Pathol"},{"issue":"1","key":"4162_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","volume":"142","author":"T Yamada","year":"2014","unstructured":"Yamada T, Okuda Y, Kushida M, Sumida K, Takeuchi H, Nagahori H, Fukuda T, Lake BG, Cohen SM, Kawamura S (2014) Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. Toxicol Sci 142(1):137\u2013157","journal-title":"Toxicol Sci"},{"issue":"5","key":"4162_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/10408444.2021.1939654","volume":"51","author":"T Yamada","year":"2021","unstructured":"Yamada T, Cohen SM, Lake BG (2021) Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit Rev Toxicol 51(5):373\u2013394","journal-title":"Crit Rev Toxicol"},{"key":"4162_CR50","first-page":"1","volume":"25","author":"T Yamada","year":"2025","unstructured":"Yamada T, Cohen SM, Lake BG (2025) The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARalpha) are not relevant to human cancer risk: an updated critical evaluation. Crit Rev Toxicol 25:1\u201338","journal-title":"Crit Rev Toxicol"},{"issue":"20","key":"4162_CR51","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.1158\/0008-5472.CAN-04-1459","volume":"64","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR (2004) The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64(20):7197\u20137200","journal-title":"Cancer Res"},{"key":"4162_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2025.105834","volume":"160","author":"J Yano","year":"2025","unstructured":"Yano J, Kawamoto K, Shimotsuma Y, Matsunaga K, Abe J, Fukunaga S, Osimitz TG, Lake BG, Asano H (2025) Mode of action analysis for rat thyroid gland follicular cell tumor formation by MGK-264 and human relevance. Regul Toxicol Pharmacol 160:105834","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1\u20132","key":"4162_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/10408440601123446","volume":"37","author":"RT Zoeller","year":"2007","unstructured":"Zoeller RT, Tan SW, Tyl RW (2007) General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol 37(1\u20132):11\u201353","journal-title":"Crit Rev Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04162-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T01:02:32Z","timestamp":1759107752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04162-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4162"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04162-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Samuel M. Cohen consults for Sumitomo Chemical Company, Ltd. The other authors are employed by Sumitomo Chemical Company, Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}